Form 8-K · Current report
U.S. Bancorp 8-K, filed Oct 15, 2026
- Filed
- CIK
- 0000036104
- Accession no.
- 0000036104-26-000054
Summary
U.S. Bancorp reported third-quarter 2026 net income attributable to the company of $2,202 million, or $1.34 per diluted common share, on record net revenue of $7,970 million, with year-over-year increases of 10.0% in net income and 9.8% in diluted earnings per share. The company said it completed a live cross-border payment pilot using its USBDC U.S. dollar-backed stablecoin on the Stellar blockchain and launched two small-business credit cards.
Key points
- Net income attributable to U.S. Bancorp was $2,202 million, up 10.0% year over year, and diluted earnings per common share were $1.34, up 9.8%.
- Net revenue reached a record $7,970 million, with net interest income up 5.6% and fee revenue up 14.9% from the prior-year quarter; net interest margin was 2.84%.
- U.S. Bank completed a live pilot cross-border payment using USBDC, its U.S. dollar-backed stablecoin, on the Stellar blockchain.
- U.S. Bank launched Business Essentials and Business Essentials Plus small-business credit cards, with Jessica Alba as spokesperson.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 15, 2026, U.S. Bancorp (the “Company”) issued a press release reporting financial results for the quarter ended September 30, 2026. The press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference. The press release contains forward-looking statements regarding the Company and includes a cautionary statement identifying important factors that could cause actual results to differ materially from those anticipated. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.